Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials-Reference-Cited by-同舟云学术

Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials

Published:2003-04 Issue: Volume:40 Page:92-97
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Guilhot François,Gardembas Martine,Rousselot Philippe,Tulliez Michel,Vigier Magda,Buzyn Agnès,Rigal-Huguet Françoise,Legros Laurence,Michallet Mauricette,Berthou Christian,Najman Albert,Maloisel Frederic,Mahon François-Xavier,Facon Thierry,Berthaud Patrice,Guilhot Joëlle

Publisher

Elsevier BV

Subject

Hematology

Reference38 articles.

1. Chronic myeloid leukemia and interferon-α: A study of complete cytogenetic responders;Bonifazi;Blood,2001

2. High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance;Branford;Blood,2002

3. Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia;Chase;Blood,2000

4. Persistance of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after Interferon-α therapy or allogenic bone marrow transplantation;Chomel;Blood,2000

5. A dose-escalating phase I/II study of imatinib (Glivec) and cytarabin in first chronic phase chronic myeloid leukemia;Cornelissen;Blood,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide;Experimental Biology and Medicine;2013-07-24

2. Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma;Reviews on Recent Clinical Trials;2007-05-01

3. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis;Anti-Cancer Drugs;2006-07

4. Treating Imatinib-Resistant Leukemia: The Next Generation Targeted Therapies;The Scientific World JOURNAL;2006

5. Combined Abl Inhibitor Therapy for Minimizing Drug Resistance in Chronic Myeloid Leukemia: Src/Abl Inhibitors Are Compatible with Imatinib;Clinical Cancer Research;2005-10-01